[HTML][HTML] Cancer stem cells (CSCs), circulating tumor cells (CTCs) and their interplay with cancer associated fibroblasts (CAFs): a new world of targets and treatments

B Aramini, V Masciale, C Arienti, M Dominici, F Stella… - Cancers, 2022 - mdpi.com
Simple Summary The world of small molecules in solid tumors as cancer stem cells (CSCs),
circulating tumor cells (CTCs) and cancer-associated fibroblasts (CAFs) continues to be …

Updates of liquid biopsy in oral cancer and multiomics analysis

X Zhang, B Li - Oral Diseases, 2023 - Wiley Online Library
Liquid biopsy is a method sampled from body fluids, such as blood, saliva, urine, pleural
effusion, cerebrospinal fluid, and so on. It is minimally invasive and reproducible and …

[HTML][HTML] Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer

Y Xu, X Ren, T Jiang, S Lv, K Gao, Y Liu, Y Yan - BMC cancer, 2023 - Springer
Abstract Background Circulating tumor cells (CTCs) are important biological indicators of the
lung cancer prognosis, and CTC counting and typing may provide helpful biological …

Advances in liquid biopsy–based markers in NSCLC

XD Ren, N Su, XG Sun, WM Li, J Li, BW Li, RX Li… - Advances in Clinical …, 2023 - Elsevier
Lung cancer is the second most–frequently occurring cancer and the leading cause of
cancer–associated deaths worldwide. Non–small cell lung cancer (NSCLC), the most …

The Tumor Microenvironment Affects Circulating Tumor Cells Metastasis and the Efficacy of Immune Checkpoint Blockade in Non-small Cell Lung Cancer

X Zhang, S Qiu, C Wang - Current Cancer Drug Targets, 2024 - ingentaconnect.com
Lung cancer is one of the most lethal malignancies, with non-small cell lung cancer
(NSCLC) being the most common histologic subtype. Metastasis leads to poor prognosis for …

[HTML][HTML] Predictive Value of Circulating Tumor Cells Detected by ISET® in Patients with Non-Metastatic Prostate Cancer Undergoing Radical Prostatectomy

LN Garrido Castillo, A Mejean, P Vielh, J Anract… - Life, 2022 - mdpi.com
There is an unmet need for reliable biomarkers to predict prostate cancer recurrence after
prostatectomy in order to better guide the choice of surgical treatment. We have evaluated …